Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate
Source abstract
Abstract
Culture of expanded mesenchymal stem cells (MSCs) seeded on biomaterials may represent a clinical alternative to autologous bone graft in bone regeneration. Foetal bovine serum (FBS) is currently used for MSC expansion, despite risks of infectious disease transmission and immunological reaction due to its xenogenic origin. This study aimed to compare the osteogenic capacities of clinical-grade human MSCs cultured with FBS or allogenic human platelet lysate (PL). In vitro, MSCs cultured in PL both accelerate the expansion rate over serial passages and spontaneously induce osteoblastic gene expression such as alkaline phosphatase (ALP), bone sialoprotein (BSP), osteopontin (Op) and bone morphogenetic protein-2 (BMP-2). In vivo, ectopic bone formation is only observed on ceramics seeded with MSCs grown in PL medium implanted under the skin of immunodeficient mice for 7 weeks. In conclusion, allogenic human PL accelerates MSC proliferation and enhances MSC osteogenic differentiation.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Periodontal Regeneration and Treatments · Mesenchymal stem cell research · dental development and anomalies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Mesenchymal stem cells10.1002/jor.1100090504 ↗
2. Stromal stem cells: marrow-derived osteogenic precursors
3. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair10.1002/jcp.21592 ↗
4. Mesenchymal stem cells as mediators of neural differentiation10.2174/157488808783489471 ↗
5. Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis–a preliminary result of three cases10.1016/j.bone.2004.06.013 ↗
6. Marrow stromal cells as stem cells for nonhematopoietic tissues10.1126/science.276.5309.71 ↗
7. Repair of large bone defects with the use of autologous bone marrow stromal cells10.1056/NEJM200102013440516 ↗
8. Tissue-engineered bone regeneration10.1038/79449 ↗
9. Human marrow mesenchymal stem cell culture: serum-free medium allows better expansion than classical alpha-MEM medium10.1111/j.1600-0609.2005.00611.x ↗
10. Platelet alpha-granules10.1016/0268-960X(93)90024-X ↗
11. Effects of platelet growth factors on human mesenchymal stem cells and human endothelial cells in vitro
12. Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells10.1089/ten.2006.12.3067 ↗
13. Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts10.1038/sj.bmt.1705798 ↗
14. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications10.1002/jcp.20391 ↗
15. Comparison of platelet-rich plasma, bovine porous bone mineral, and guided tissue regeneration versus platelet-rich plasma and bovine porous bone mineral in the treatment of intrabony defects: a reentry study10.1902/jop.2002.73.2.198 ↗
16. Platelet-rich plasma: growth factor enhancement for bone grafts10.1016/S1079-2104(98)90029-4 ↗
17. Stromal stem cells and platelet-rich plasma improve bone allograft integration10.1097/01.blo.0000165736.87628.12 ↗
18. Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration10.1089/1076327041348284 ↗
19. Influence of platelet-rich plasma (PRP) on osteogenic differentiation of rat bone marrow stromal cells. An in vitro study10.1054/ijom.2003.0492 ↗
20. Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions10.1080/09537100310001643999 ↗
21. Influence of platelet-rich plasma on osteogenic differentiation of mesenchymal stem cells and ectopic bone formation in calcium phosphate ceramics10.1159/000095511 ↗
22. Platelet-rich plasma inhibits demineralized bone matrix-induced bone formation in nude mice10.2106/00004623-200701000-00019 ↗
23. Platelet-rich plasma enhances human osteoblast-like cell proliferation and differentiation10.1016/j.joms.2004.07.016 ↗
24. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model10.1242/jcs.113.7.1161 ↗
25. Human bone marrow stromal cells express an osteoblastic phenotype in culture10.1007/BF02631426 ↗
26. Effects of continuous dexamethasone treatment on differentiation capabilities of bone marrow-derived mesenchymal cells10.1016/j.bone.2007.06.022 ↗
27. Glucocorticoids induce the differentiation of a mesenchymal progenitor cell line, ROB-C26 into adipocytes and osteoblasts, but fail to induce terminal osteoblast differentiation10.1016/j.bone.2006.07.012 ↗
28. Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation10.1073/pnas.95.18.10614 ↗
29. Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains differentiation capacity and in vivo bone formation in calcium phosphate ceramics10.1080/09537100600758867 ↗
30. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts10.1111/j.1600-0501.2005.01203.x ↗
31. Comparison of platelet, leukocyte, and growth factor levels in point-of-care platelet-enriched plasma, prepared using a modified Curasan kit, with preparations received from a local blood bank10.1034/j.1600-0501.2003.00810.x ↗
32. Effects of platelet-rich plasma on bone healing in combination with autogenous bone and bone substitutes in critical-size defects. An animal experiment10.1111/j.1600-0501.2004.00980.x ↗
33. Platelet-rich plasmas: growth factor content and roles in wound healing10.1177/154405910508400507 ↗
34. Insulin-like growth factor-I induces early osteoblast gene expression in human mesenchymal stem cells10.1089/scd.2005.14.621 ↗
35. Localization of bone morphogenetic proteins (BMPs)-2, -4, and -6 within megakaryocytes and platelets10.1016/j.bone.2004.08.020 ↗
36. Heparan sulfate mediates the proliferation and differentiation of rat mesenchymal stem cells
37. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation10.1016/S0092-8674(01)00622-5 ↗
38. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha10.1074/jbc.M106339200 ↗
39. runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: evidence for promoter context-dependent activity of Cbfa proteins10.1128/MCB.21.8.2891-2905.2001 ↗
40. Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V ↗
41. Dynamics of gene expression during bone matrix formation in osteogenic cultures derived from human embryonic stem cells in vitro10.1016/j.bbagen.2008.10.004 ↗
42. BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways10.1074/jbc.M503845200 ↗
43. BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation10.1074/jbc.M801774200 ↗
44. Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, beta-glycerolphosphate, and l-ascorbic acid10.1002/(SICI)1097-4644(19981001)71:1<55::AID-JCB6>3.0.CO;2-0 ↗
45. In vitro dexamethasone pretreatment enhances bone formation of human mesenchymal stem cells in vivo10.1002/jor.20838 ↗
46. Effect of platelet-rich plasma on the in vitro proliferation and osteogenic differentiation of human mesenchymal stem cells on distinct calcium phosphate scaffolds: the specific surface area makes a difference10.1177/0885328207088269 ↗